EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Interconnection between polycystic ovary syndrome, immune disorders, and reproductive outcomes

Thaís Bastos Romero, Daniel de Sousa Sobral, Lara Andryne Alves Aguiar, Helena Aben-Athar Ponte, Ricardo Espíndola Romero Filho, Ana Luiza Rangel Montenegro, Marla Girão Ramos Maia, Thiago Gonçalves Marques, Laís de Oliveira Martins, Marcelo Borges Cavalcante iD

Reproduction and Fertility · 2026

DOI: 10.1530/raf-25-0186 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reproduction and Fertility, 2026. Verfasst von Thaís Bastos Romero und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Medical Sciences, Universidade de Fortaleza (UNIFOR), Fortaleza, CE, Brazil. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Infertility, Female, Immune System Diseases, Reproduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a multifactorial disorder traditionally recognized for its endocrine and metabolic disturbances. However, accumulating evidence indicates that chronic low-grade inflammation and immune dysregulation play a central role in its pathophysiology. This narrative review explores the immunological mechanisms underlying PCOS and their repercussions for reproductive outcomes. Women with PCOS exhibit increased circulating levels of inflammatory cytokines – including interleukin (IL)-6, IL-1β, IL-18, and tumor necrosis factor-alpha (TNF-α) – alongside macrophage and lymphocyte infiltration within ovarian and endometrial tissues. These alterations promote oxidative stress, granulosa cell apoptosis, impaired steroidogenesis, and diminished endometrial receptivity. The adaptive immune response is similarly altered, characterized by imbalances between Th1/Th2 and Th17/regulatory T lymphocyte subsets and the presence of autoantibodies, including antinuclear, antithyroid, and antiphospholipid antibodies. These immune abnormalities have been associated with implantation failure and recurrent pregnancy loss. Furthermore, autoimmune diseases, including Hashimoto’s thyroiditis and type 1 diabetes mellitus, occur more frequently among women with PCOS, reinforcing the concept of an underlying systemic immunometabolic imbalance. Unlike prior reviews, this work offers a novel integrative framework that connects systemic inflammation with localized immune dysregulation in reproductive tissues, providing a more comprehensive understanding of PCOS pathophysiology from an immunological standpoint. This review also discusses the immunological implications of metabolic therapies – including metformin and glucagon-like peptide-1 receptor agonists – and the prospective role of targeted immunomodulation in selected immune-phenotypic PCOS subgroups. Understanding PCOS through an immunological lens provides a new framework for integrating metabolic, hormonal, and immune pathways, guiding future personalized interventions to improve reproductive outcomes. Lay summary Polycystic ovary syndrome (PCOS) is one of the most common causes of infertility in women and involves not only hormonal and metabolic problems but also immune system dysregulation. Women with PCOS often experience chronic low-grade inflammation involving the ovaries and uterus, which can impair egg quality and hinder successful embryo implantation. They are also more prone to autoimmune diseases, including thyroid disorders, which can contribute to pregnancy complications and miscarriages. This review synthesizes recent studies showing how immune cells and inflammatory molecules interfere with fertility in PCOS and how certain existing treatments – such as metformin and glucagon-like peptide-1 receptor agonists – may also help by improving immune balance. Understanding these immune mechanisms will help researchers and clinicians develop more targeted and effective therapies, supporting women with PCOS in achieving healthier pregnancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeInfertility, FemaleImmune System DiseasesReproductionHumansFemalePregnancyPregnancy Outcome

Stichwörter der Autor:innen

immune system diseasesimmunologypolycystic ovary syndromepregnancy outcome

Autor:innen und Institutionen

  • Graduate Program in Medical Sciences, Universidade de Fortaleza (UNIFOR), Fortaleza, CE, Brazil.
  • Medical School, Universidade de Fortaleza (UNIFOR), Fortaleza, CE, Brazil.
  • Veterinary Medicine School, Universidade de Fortaleza (UNIFOR), Fortaleza, CE, Brazil.

ORCID-Profile: Marcelo Borges Cavalcante

Zitieren

APA

Romero, T. B., de Sousa Sobral, D., Aguiar, L. A. A., Ponte, H. A., Romero Filho, R. E., Montenegro, A. L. R., Maia, M. G. R., Marques, T. G., de Oliveira Martins, L., & Cavalcante, M. B. (2026). Interconnection between polycystic ovary syndrome, immune disorders, and reproductive outcomes. Reproduction and Fertility. https://doi.org/10.1530/raf-25-0186

Vancouver

Romero TB, de Sousa Sobral D, Aguiar LAA, Ponte HA, Romero Filho RE, Montenegro ALR, et al. Interconnection between polycystic ovary syndrome, immune disorders, and reproductive outcomes. Reproduction and Fertility. 2026. doi:10.1530/raf-25-0186

BibTeX
@article{Romero2026,
  author = {Romero, Thaís Bastos and de Sousa Sobral, Daniel and Aguiar, Lara Andryne Alves and Ponte, Helena Aben-Athar and Romero Filho, Ricardo Espíndola and Montenegro, Ana Luiza Rangel and Maia, Marla Girão Ramos and Marques, Thiago Gonçalves and de Oliveira Martins, Laís and Cavalcante, Marcelo Borges},
  title = {Interconnection between polycystic ovary syndrome, immune disorders, and reproductive outcomes},
  journal = {Reproduction and Fertility},
  year = {2026},
  doi = {10.1530/raf-25-0186}
}
Kostenlos starten →